Verification of a Western Nomogram for Predicting Oncotype DX™ Recurrence Scores in Korean Patients with Breast Cancer.

about

Verification of a Western Nomogram for Predicting Oncotype DX™ Recurrence Scores in Korean Patients with Breast Cancer.

Item

http://www.wikidata.org/entity/Q55371177

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Verification of a Western Nomo ...... n Patients with Breast Cancer.

@en

Verification of a Western Nomo ...... n Patients with Breast Cancer.

@nl

type

Item

label

Verification of a Western Nomo ...... n Patients with Breast Cancer.

@en

Verification of a Western Nomo ...... n Patients with Breast Cancer.

@nl

altLabel

Verification of a Western Nomo ...... an Patients with Breast Cancer

@en

prefLabel

Verification of a Western Nomo ...... n Patients with Breast Cancer.

@en

Verification of a Western Nomo ...... n Patients with Breast Cancer.

@nl

P1476

Verification of a Western Nomo ...... n Patients with Breast Cancer.

@en

P2093

Hee Jun Choi

http://www.w3.org/2001/XMLSchema#string

Isaac Kim

http://www.w3.org/2001/XMLSchema#string

Jae-Myung Kim

http://www.w3.org/2001/XMLSchema#string

Jai Min Ryu

http://www.w3.org/2001/XMLSchema#string

Jeong Eon Lee

http://www.w3.org/2001/XMLSchema#string

Jonghan Yu

http://www.w3.org/2001/XMLSchema#string

Se Kyung Lee

http://www.w3.org/2001/XMLSchema#string

Seok Jin Nam

http://www.w3.org/2001/XMLSchema#string

Seok Won Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis.

Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data.

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

The clinical impact of 21-gene recurrence score on treatment decisions for patients with hormone receptor-positive early breast cancer in Korea.

Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.

Oncotype Dx recurrence score among BRCA1/2 germline mutation carriers with hormone receptors positive breast cancer.

Pooled analysis of prospective European studies assessing the impact of using the 21-gene Recurrence Score assay on clinical decision making in women with oestrogen receptor-positive, human epidermal growth factor receptor 2-negative early-stage bre

Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival.

The Relationship of Race, Oncotype DX, and Ki67 in a Population Highly Screened For Breast Cancer.

P304

222-226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4048/JBC.2018.21.2.222

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29963119

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6015974

http://www.w3.org/2001/XMLSchema#string